Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 1/20 | 0.32 |
| ▸ | SCN4A | P35499 | 1/20 | 0.32 |
| ▸ | SCN7A | Q01118 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.32 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.32 |
| ▸ | SCN11A | Q9UI33 | 1/20 | 0.32 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18817874 | 0.89 | SCN1A (0.33) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL7164910 | 0.86 | SCN1A (0.37) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL11572260 | 0.84 | SCN1A (0.38) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL4748922 | 0.80 | SCN1A (0.39) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL4012058 | 0.80 | SCN1A (0.39) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL18638577 | 0.80 | — | — | |
| SCHEMBL1814570 | 0.79 | SCN1A (0.42) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL4655181 | 0.79 | SCN1A (0.32) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL4654056 | 0.76 | SCN1A (0.31) | SCN1ASCN4ASCN7AKCNH2SCN5A | |
| SCHEMBL4655278 | 0.76 | SCN1A (0.41) | SCN1ASCN4ASCN7AKCNH2SCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230089292-A1 | SELF HEALING LITHIUM-ION BATTERY | StoreDot Ltd. (IL) | 2023-03-23 | — | — | US | claimed |
| US-20230089292-A1 | SELF HEALING LITHIUM-ION BATTERY | StoreDot Ltd. (IL) | 2023-03-23 | — | — | US | disclosed |
| EP-2267062-B1 | SUPRAMOLECULAR POLYMERS CONTAINING QUADRUPLE HYDROGEN BONDING UNITS IN THE POLYMER BACKBONE | SUPRAPOLIX BV (NL) | 2017-10-25 | — | — | EP | disclosed |
| US-9790394-B2 | Floor coating compositions containing supramolecular polymers | ROHM AND HAAS COMPANY (US) | 2017-10-17 | — | — | US | disclosed |
| EP-1773903-B1 | SUPRAMOLECULAR IONOMERS | SUPRAPOLIX BV (NL) | 2017-08-09 | — | — | EP | disclosed |
| EP-3016996-B1 | FLOOR COATING COMPOSITIONS CONTAINING SUPRAMOLECULAR POLYMERS | ROHM & HAAS (US) | 2017-06-14 | — | — | EP | disclosed |
| US-20160230035-A1 | FLOOR COATING COMPOSITIONS CONTAINING SUPRAMOLECULAR POLYMERS | ROHM AND HAAS COMPANY | 2016-08-11 | — | — | US | disclosed |
| EP-1534688-B1 | MONOMERS CAPABLE OF FORMING FOUR HYDROGEN BRIDGES AND SUPRAMOLECULAR POLYMERS FORMED BY COPOLYMERIZATION OF THESE MONOMERS WITH REGULAR MONOMERS | SUPRAPOLIX BV (NL) | 2014-10-29 | — | — | EP | disclosed |
| US-8268952-B2 | Supramolecular ionomers | SUPRAPOLIX B.V. (NL) | 2012-09-18 | — | — | US | disclosed |
| US-8247524-B2 | Preparation of supramolecular polymers containing quadruple hydrogen bonding units in the polymer backbone | SUPRAPOLIX B.V. (NL) | 2012-08-21 | — | — | US | disclosed |
| EP-1687378-A1 | PREPARATION OF SUPRAMOLECULAR POLYMERS CONTAINING QUADRUPLE HYDROGEN BONDING UNITS IN THE POLYMER BACKBONE | SupraPolix B.V. (NL) | 2006-08-09 | — | — | EP | disclosed |
| US-20060018856-A1 | Siloxane polymers with quadruple hydrogen bonding units | SUPRAPOLIX B.V. (NL) | 2006-01-26 | — | — | US | disclosed |
| WO-2006006855-A1 | SUPRAMOLECULAR IONOMERS | SUPRAPOLIX B.V. (NL) | 2006-01-19 | — | — | WO | disclosed |
| EP-1569984-A1 | SILOXANE POLYMERS WITH QUADRUPLE HYDROGEN BONDING UNITS | SupraPolix B.V. (NL) | 2005-09-07 | — | — | EP | disclosed |
| EP-1534688-A1 | MONOMERS CAPABLE OF FORMING FOUR HYDROGEN BRIDGES AND SUPRAMOLECULAR POLYMERS FORMED BY COPOLYMERIZATION OF THESE MONOMERS WITH REGULAR MONOMERS | SupraPolix B.V. (NL) | 2005-06-01 | — | — | EP | disclosed |
| WO-2005042641-A1 | PREPARATION OF SUPRAMOLECULAR POLYMERS CONTAINING QUADRUPLE HYDROGEN BONDING UNITS IN THE POLYMER BACKBONE | SUPRAPOLIX B.V. (NL) | 2005-05-12 | — | — | WO | disclosed |
| US-6803447-B2 | Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers | EUTECHPARK MMP1.28 (NL) | 2004-10-12 | — | — | US | disclosed |
| WO-2004052963-A1 | SILOXANE POLYMERS WITH QUADRUPLE HYDROGEN BONDING UNITS | SUPRAPOLIX B.V. (NL) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004016598-A1 | MONOMERS CAPABLE OF FORMING FOUR HYDROGEN BRIDGES AND SUPRAMOLECULAR POLYMERS FORMED BY COPOLYMERIZATION OF THESE MONOMERS WITH REGULAR MONOMERS | SUPRAPOLIX, B.V. (NL) | 2004-02-26 | — | — | WO | disclosed |
| US-20040034190-A1 | Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers | SUPRAPOLIX B.V. (NL) | 2004-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018856-A1 | Siloxane polymers with quadruple hydrogen bonding units | VCL, CD44, HSPA4L | SCN1A 3948/4885SCN4A 1399/4885SCN7A 3370/4885 |
| US-20040034190-A1 | Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers | PCNA, PYM1, PARG | SCN1A 4554/4885SCN4A 3572/4885SCN7A 4787/4885 |
| US-20230089292-A1 | SELF HEALING LITHIUM-ION BATTERY | ILK, CCNI, NEK9 | SCN1A 922/4885SCN4A 546/4885SCN7A 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.